51 research outputs found

    VI. Perspectives

    Get PDF
    [934] Sans acquérir de significations fondamentalement nouvelles, les notions en elles-mêmes « amorphes » et neutres de Macht et de Gewalt recouvrent plus que jamais, au XXe siècle, un large spectre sémantique dans les champs de la terminologie des sciences politiques et sociales et du langage politico-idéologique, qui se recoupent. Au gré des innombrables théories de la puissance et du pouvoir, la discussion scientifique a largement suivi, en partie en les approuvant ou en les modifiant, en..

    III. La fonction systémique de la « puissance » et du « pouvoir » au Moyen Âge

    Get PDF
    1. Remarque préliminaire sur l’évolution du vocabulaire et de la terminologieLe substantif Gewalt (giwalt en vieux haut allemand) vient du verbe walten, qui constitue une extension de la racine indo-européenne *ual et signifie à l’origine « avoir de la force », « disposer de », « dominer ». Dès le départ, le terme posséda une pluralité de significations, qui se regroupèrent sous la forme d’expressions fixes ou plus souples, dans le prolongement des traditions antiques associées aux champs sé..

    From empirics to empiricists

    Full text link

    ARTEFACTS: How do we want to deal with the future of our one and only planet?

    Get PDF
    The European Commission’s Science and Knowledge Service, the Joint Research Centre (JRC), decided to try working hand-in-hand with leading European science centres and museums. Behind this decision was the idea that the JRC could better support EU Institutions in engaging with the European public. The fact that European Union policies are firmly based on scientific evidence is a strong message which the JRC is uniquely able to illustrate. Such a collaboration would not only provide a platform to explain the benefits of EU policies to our daily lives but also provide an opportunity for European citizens to engage by taking a more active part in the EU policy making process for the future. A PILOT PROGRAMME To test the idea, the JRC launched an experimental programme to work with science museums: a perfect partner for three compelling reasons. Firstly, they attract a large and growing number of visitors. Leading science museums in Europe have typically 500 000 visitors per year. Furthermore, they are based in large European cities and attract local visitors as well as tourists from across Europe and beyond. The second reason for working with museums is that they have mastered the art of how to communicate key elements of sophisticated arguments across to the public and making complex topics of public interest readily accessible. That is a high-value added skill and a crucial part of the valorisation of public-funded research, never to be underestimated. Finally museums are, at present, undergoing something of a renaissance. Museums today are vibrant environments offering new techniques and technologies to both inform and entertain, and attract visitors of all demographics.JRC.H.2-Knowledge Management Methodologies, Communities and Disseminatio

    Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

    Get PDF
    Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049

    The genetic architecture of the human cerebral cortex

    Get PDF
    The cerebral cortex underlies our complex cognitive capabilities, yet little is known about the specific genetic loci that influence human cortical structure. To identify genetic variants that affect cortical structure, we conducted a genome-wide association meta-analysis of brain magnetic resonance imaging data from 51,665 individuals. We analyzed the surface area and average thickness of the whole cortex and 34 regions with known functional specializations. We identified 199 significant loci and found significant enrichment for loci influencing total surface area within regulatory elements that are active during prenatal cortical development, supporting the radial unit hypothesis. Loci that affect regional surface area cluster near genes in Wnt signaling pathways, which influence progenitor expansion and areal identity. Variation in cortical structure is genetically correlated with cognitive function, Parkinson's disease, insomnia, depression, neuroticism, and attention deficit hyperactivity disorder

    I. Introduction

    Get PDF
    La « puissance » [Macht] que Weber définit comme « toute chance, au sein d’une relation sociale, d’imposer sa volonté propre, y compris en dépit d’une résistance, peu importe sur quoi repose cette chance », et le « pouvoir » [Gewalt], d’abord compris, dans la conception moderne, comme « emploi de la contrainte », renvoient à des réalités fondamentales de la vie en commun des êtres humains. Les champs sémantiques de ces deux notions, qui ne se recouvrent aucunement, mais s’imbriquent dans une..
    corecore